Publications

Found 9 results
Filters: Author is Xavier, Catarina  [Clear All Filters]
2016
Massa, S., N. Vikani, C. Betti, S. Ballet, S. Vanderhaegen, J. Steyaert, B. Descamps, C. Vanhove, A. Bunschoten, F. W. B. van Leeuwen, et al., "Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.", Contrast Media Mol Imaging, vol. 11, issue 5, pp. 328-339, 2016 09.
2014
D'huyvetter, M., C. Xavier, V. Caveliers, T. Lahoutte, S. Muyldermans, and N. Devoogdt, "Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.", Expert Opin Drug Deliv, vol. 11, issue 12, pp. 1939-54, 2014 Dec.
Massa, S., C. Xavier, J. De Vos, V. Caveliers, T. Lahoutte, S. Muyldermans, and N. Devoogdt, "Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.", Bioconjug Chem, vol. 25, issue 5, pp. 979-88, 2014 May 21.
De Vos, J., I. Mathijs, C. Xavier, S. Massa, U. Wernery, L. Bouwens, T. Lahoutte, S. Muyldermans, and N. Devoogdt, "Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.", Mol Imaging Biol, vol. 16, issue 5, pp. 690-8, 2014 Oct.
D'huyvetter, M., C. Vincke, C. Xavier, A. Aerts, N. Impens, S. Baatout, H. De Raeve, S. Muyldermans, V. Caveliers, N. Devoogdt, et al., "Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody.", Theranostics, vol. 4, issue 7, pp. 708-20, 2014.
2013
Xavier, C., I. Vaneycken, M. D'huyvetter, J. Heemskerk, M. Keyaerts, C. Vincke, N. Devoogdt, S. Muyldermans, T. Lahoutte, and V. Caveliers, "Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.", J Nucl Med, vol. 54, issue 5, pp. 776-84, 2013 May.
2012
D'huyvetter, M., A. Aerts, C. Xavier, I. Vaneycken, N. Devoogdt, M. Gijs, N. Impens, S. Baatout, B. Ponsard, S. Muyldermans, et al., "Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.", Contrast Media Mol Imaging, vol. 7, issue 2, pp. 254-64, 2012 Mar-Apr.
2011
Gainkam, L. Olive Tcho, V. Caveliers, N. Devoogdt, C. Vanhove, C. Xavier, O. Boerman, S. Muyldermans, A. Bossuyt, and T. Lahoutte, "Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.", Contrast Media Mol Imaging, vol. 6, issue 2, pp. 85-92, 2011 Mar-Apr.
Vaneycken, I., N. Devoogdt, N. Van Gassen, C. Vincke, C. Xavier, U. Wernery, S. Muyldermans, T. Lahoutte, and V. Caveliers, "Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.", FASEB J, vol. 25, issue 7, pp. 2433-46, 2011 Jul.